During the past decade, Dr. med Friedrich Kaiser conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dr. med Friedrich Kaiser" are "Attention Deficit Hyperactivity Disorder (ADHD)" (1 trials), "Head Lice Infestation" (1 trials), "Lice" (1 trials), "Pediculosis Capitis" (1 trials) and "Seasonal Allergic Conjunctivitis" (1 trials). Many other conditions were trialed in "Dr. med Friedrich Kaiser" in a lesser frequency.

Most popular intervention types in "Dr. med Friedrich Kaiser" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dimet 5" (1 trials), "Extended-release Guanfacine HCl (Intuniv, SPD503)" (1 trials), "Placebo products" (1 trials) and "ect4allergy Nasal Spray (ANS01) and Eye Drops (AAT01)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr. med Friedrich Kaiser" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Dr. med Friedrich Kaiser". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dr. med Friedrich Kaiser, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dr. med Friedrich Kaiser, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".